CBD Oil: The Science Behind This Cannabis Plant Extract

Cannabidiol (CBD) is a cannabinoid that is mixed with a carrier oil to make CBD oil.

Cannabinoids act on the body's endocannabinoid system to regulate anxiety, mood, and appetite. CBD is extracted from cannabis plants (e.g., Cannabis indica, Cannabis sativa, and Cannabis ruderalis). However, the hemp plant (Cannabis ruderalis) typically contains higher quantities of CBD.

The other main component of Cannabis indica and Cannabis sativa species—but not typically Cannabis ruderalis—is delta-9-tetrahydrocannabinol (THC).

THC can cause a sense of euphoria but can also cause other sensations, like paranoia. CBD oil should not contain more than 0.3% THC, so it does not typically cause a feeling of euphoria—so many people assume it's safe, although it may not be, especially for specific populations.

CBD has been studied for its use in seizures, chronic pain, anxiety, inflammation, and more. However, varying levels of scientific evidence exist for these claims, meaning it's unclear if CBD works for these conditions.

This article covers the latest evidence on over-the-counter (OTC) CBD—its uses, safety considerations, interactions, and what to know before you try it.

a photo composite with nutritional information about CBD Oil

Verywell / Getty Images

OTC CBD products are not regulated or standardized like prescription drugs in the United States. They can cause interactions with medications or have other safety concerns. For this reason, it’s important to be aware of what to look for when choosing a supplement, such as third-party testing, potential drug interactions, and more.

CBD Oil Benefits

CBD use should be individualized and vetted by a healthcare professional, such as a pharmacist or healthcare provider. OTC CBD oil products are not intended to treat, cure, or prevent disease.

Proponents of CBD oil claim that it benefits people with various health problems. As CBD has gained popularity, researchers have been trying to study it more—but, so far, human trials remain sparse. There is little evidence to support its myriad health claims. 

Here's a deeper dive into CBD oil's more compelling health benefits.

Note that CBD oil is different from hemp oil. Hemp oil is processed differently (pressing hemp seeds) and typically contains no CBD.

Supports Brain and Nerve Conditions

In June 2018, the FDA approved a CBD oral solution called Epidiolex. Epidiolex is a prescription drug, not an over-the-counter (OTC) product.

Epidiolex is used to treat two rare forms of epilepsy in children under 2 years: Dravet syndrome and Lennox-Gastaut syndrome. These rare genetic disorders cause lifelong seizures in the first year of life. It’s also approved for use in tuberous sclerosis complex, a rare genetic condition that causes benign tumors to grow throughout the body, often accompanied by seizures.

Keep in mind that Epidiolex is not a supplement. It requires a prescription from a healthcare provider. 

CBD has also been studied for the following:

While promising, further research is needed for these conditions. And OTC CBD products are not regulated or standardized like prescription medications such as Epidiolex. 

May Help Treat Anxiety

CBD might help treat anxiety disorders, although there have not been many trials to look at CBD's anxiety-relieving effects in humans.

In one study, 57 men took either CBD oil or a sugar pill with no CBD (placebo) before a public-speaking event. The researchers assessed the participants' anxiety levels using blood pressure and heart rate measures. The researchers also used a reliable test for mood states called the Visual Analog Mood Scale.

The men who took 300 milligrams (mg) of CBD oil reported less anxiety than the men who were given a placebo; however, the men who took 100 or 600 mg of CBD oil did not experience the same effects. This trial was limited by a small sample size and only enrolled men, so more data is needed to see if CBD has a similar impact on women.

In another double-blind placebo-controlled study (meaning neither participants nor researchers knew who took the substance and who took a placebo), CBD was also shown to decrease symptoms of Social Anxiety Disorder in teenagers. This study was well-designed but very small; only 37 people were studied.

May Assist Substance Use Disorder Treatment

CBD may be able to inhibit the rewarding and reinforcing effects of addictive substances (e.g., tobacco, cocaine, methamphetamine (METH), heroin, and morphine). While the preliminary research is promising, more is needed to confirm results. 

Might Help Treat Schizophrenia

In a randomized controlled trial of 88 people already taking medication for schizophrenia, 1,000 milligrams per day of CBD oil decreased positive psychotic symptoms (hallucinations or delusions). However, there were no significant differences between CBD oil and placebo regarding negative psychotic symptoms (like blunt affect or disinterest in others).

Also, note that CBD oil was studied as an add-on therapy here since the people in the trial were already taking prescription medicines to treat schizophrenia.

Products with significant amounts of THC may worsen symptoms of psychosis, schizophrenia, and paranoia.

May Support Sleep

There is conflicting evidence to support the use of cannabinoids to treat sleep disorders. Although some study outcomes have been favorable, most have not.

For example, a 2022 comprehensive review of the effects of cannabinoids on normal sleep and sleep disorders showed that cannabis products have minimal to no effects on sleep and may produce negative effects in some individuals. 

A 2017 study found that CBD products containing THC may decrease the time needed to fall asleep. but could also impair sleep quality in the long term. And, a 2021 meta-analysis on CBD's effects as an appetite suppressant and as a sleep aid concluded that, while there was a moderate positive impact on appetite control, CBD showed no effect on sleep.

Despite underwhelming sleep results, research is ongoing to explore specific pharmacological properties and strengths of cannabinoids that might produce the soporific (inducing drowsiness) results often theorized. However, considering the absence of hard evidence, one study puts it best by advising: "Individuals seeking cannabis-derived sleep aids should be skeptical of manufacturers' claims of sleep-promoting effects."

May Lower High Blood Pressure

CBD may produce favorable outcomes for people attempting to lower their blood pressure. Multiple recent studies have shown CBD's effectiveness in reducing blood pressure in those with hypertension.

Accumulated data (both from human and animal studies) suggest that CBD may be associated with improved cardiovascular function, marked reductions in blood pressure, and enhanced endothelial function.

Although the data is preliminary, CBD oil has also been studied for the following uses:

There’s not enough data to recommend CBD oil for any of these uses quite yet.

CBD Oil vs. Marijuana
 CBD Oil Marijuana
A component of the hemp plant Separate plant in the hemp family that contains CBD and hundreds of other compounds.
No or trace amounts of THC (0.3% or less) Significant amounts of THC
Works receptors in the brain, but not those that induce psychoactive effects (e.g., opioid receptors that help control pain, glycine receptors that impact mood control) THC binds to cannabinoid receptors in the brain to create a "high" feeling

What Are the Side Effects of CBD Oil?

Clinical research has shown that CBD oil can cause side effects. In one study, 91% of people with seizure disorders who took the prescription product Epidiolex had side effects from the medicine. The specific side effects and their severity vary from one person to the next and from one type of CBD to another.

Common Side Effects

The most common side effects of CBD oil that were reported include the following:

  • Change in appetite
  • Drowsiness or fatigue
  • Diarrhea
  • Change in liver enzymes

Severe Side Effects

Severe side effects have been noted in people with treatment-resistant epilepsy (ongoing seizures despite multiple medications). These include:

  • Status epilepticus (a life-threatening medical emergency where a seizure lasts longer than five minutes)
  • Pneumonia (infection of the air sacs in the lungs)

Also, consider that CBD products are not regulated and may be adulterated or labeled misleadingly. One study found that 21% of CBD products sold online also had THC. Severe side effects of THC, particularly at doses above 2.4 mg, can be quite severe and include:

  • Anxiety
  • Impaired cognition (lowered IQ scores and memory loss)
  • Psychosis (including suspiciousness, emotional withdrawal, and hallucinations)

If you notice these effects while using CBD oil, discontinue and discuss side effects with a healthcare provider as soon as possible.

Adolescent users are at increased risk of psychological disorders from THC. These psychological disorders include an increased risk of psychosis and schizophrenia.

Do not drive or use heavy machinery when taking CBD oil—especially when you first start using it or switch to a new brand. Remember that some products do contain THC, even in small amounts.

Precautions

Your healthcare practitioner may advise against using CBD oil if you:

  • Have liver disease: CBD oil may increase liver enzymes, a marker of liver inflammation. Talk with your healthcare provider before taking CBD oil. You may need to check your liver enzymes regularly if you use CBD.
  • Have eye issues: CBD oil may also cause eye-related side effects. A 2018 study found that it may increase pressure inside the eyes. For people with glaucoma, this can make the condition worse. Some people also report dry eyes as a side effect of CBD oil.
  • Are pregnant or nursing: You should not use CBD oil if you're pregnant or breastfeeding. Even though the effects of CBD are not fully understood, it does pass through the placenta. The American Academy of Pediatrics (AAP) further states that pregnant people should not use marijuana products because of the potential risks to developing fetuses.
  • Drink alcohol or take other sedating medications: Using CBD with these drugs could cause excess drowsiness.
  • Are a child: Children should not use CBD oil.

Product Facts

  • Active ingredient(s): Cannabidiol
  • Alternate name(s): Cannabis, Cannabis ruderalis extract, hemp plant extract
  • Legal status: Prescription drug (Epidiolex), legal in most states; not considered a dietary supplement by the FDA (FD&C Act)
  • Suggested dose: Varies based on condition. CBD is not meant to prevent, treat, or cure disease.
  • Safety considerations: Contraindicated in pregnancy and breastfeeding and not for use in children. Interacts with alcohol and many prescription medications.

Dosage: How Much CBD Oil Should I Take?

Always speak with a healthcare provider before taking a supplement to ensure that the supplement and dosage are appropriate for your individual needs. 

There are no guidelines for CBD products or a "correct" dose of CBD oil. CBD has been used in doses ranging from 40 to 1,280 mg per day. For example, in one trial, patients admitted to the emergency room for acute back pain were given a one-time dose of 400 mg of CBD oil.

In another trial, schizophrenic patients were given 600 mg per day of CBD oil for six weeks. As a general rule, never take more than the recommended dose.

What Happens if I Take Too Much CBD?

Doses of up to 1,400 mg per day seem well-tolerated in adults. Keep an eye out for serious side effects like fatigue, changes in appetite, seizures, or pneumonia. Also, be aware that CBD may be adulterated (containing unlisted ingredients such as THC) and may not contain the amount of CBD listed on the bottle.

Children can be especially vulnerable. Dangerously slowed breathing has been noted in a pediatric case report of a child who unintentionally ingested too much CBD.

CBD is also found in many foods and drinks in the U.S., so if you plan to consume these, discuss your total daily dose with your healthcare provider.

If you have questions or concerns about the use or unintended (accidental) ingestion of CBD products, contact your healthcare provider, health department, or local or regional Poison Control Center at 800-222-1222. Call 911 in case of emergency.

Interactions

CBD oil can interact with medications, including many used to treat epilepsy. One of the reasons for this has to do with how your body breaks down (metabolizes) drugs.

Cytochrome P450 (CYP450) is a liver enzyme your body uses to break down some drugs. CBD oil is broken down by and can also affect  CYP450. That means taking CBD oil with these drugs could have a more substantial effect than you need or make them not work as well.

Drugs that could potentially interact with CBD include:

  • Anticonvulsants like phenobarbital, Lamictal (lamotrigine), Onfi (clobazam), Dilantin (phenytoin), Tegretol (carbamazepine) and Trileptal (oxcarbazepine). In general, these will decrease the level of CBD. CBD increases lamotrigine levels.
  • Antidepressants like Paxil (paroxetine), Celexa (citalopram), Remeron (mirtazapine), and Tofranil (imipramine). CBD may increase the levels of these medicines and exacerbate their side effects.
  • Antifungals like ketoconazole
  • Antipsychotics like Haldol (haloperidol)
  • Benzodiazepine sedatives like Klonopin (clonazepam), Ativan (lorazepam), and Valium (diazepam). CBD decreases the effect of clonazepam and increases the impact of the others, which may increase side effects like drowsiness.
  • Echinacea species 
  • Erectile dysfunction drugs like Viagra (sildenafil)
  • Immune-suppressants like Sandimmune (cyclosporine). CBD may increase the levels of these drugs.
  • Macrolide antibiotics like clarithromycin 
  • Opioid painkillers like morphine. CBD increases the effect of morphine.
  • Rifampin-based drugs used to treat tuberculosis.
  • Statins to treat cholesterol like Lipitor (atorvastatin) and Zocor (simvastatin)

Always tell your healthcare provider and pharmacist about all your medicines, including prescription, OTC, herbal, or recreational drugs. Alcohol or other recreational drugs that cause drowsiness may have increased side effects if used with CBD oil.

The interactions between these medications and CBD may be mild, and you might not have to change your treatment. However, in some cases, you might have to change drugs or space out your doses to avoid a reaction. Never change or stop medication without talking to your provider.

It is essential to carefully read a product's ingredient list and nutrition facts panel to know which ingredients and how much of each ingredient is included. Please review this supplement label with your healthcare provider to discuss potential interactions with foods, other supplements, and medications.

Sources of CBD Oil and What to Look For

CBD can be derived from two types of cannabis plants: marijuana, which has a higher amount of THC, and hemp, which has a low amount of THC. Since 2018, the FDA has allowed CBD products to be sold as long as they have less than 0.3% THC. The FDA has made it illegal for companies to market CBD as dietary supplements or to claim that they treat specific conditions.

Remember that CBD oils are unregulated. There's no guarantee that a product is what it claims to be on its packaging. You also can't know for sure that it's safe and effective. 

A 2017 study reported that only 31% of CBD products sold online were correctly labeled. Most had less CBD in them than was advertised, and 21% had significant amounts of THC.

Summary

The FDA does not regulate CBD oil, and contrary to popular opinion, it does come with some risks. Until more research is done on CBD oil, it's important to remember that it may not live up to the hype and could even be dangerous. CBD products have not shown strong evidence of benefit for most of the advertised conditions.

There is significant variability among the products you'll find at dispensaries, smoke shops, or online. Each product can contain very different amounts of CBD or THC than what's listed on the package and can also contain harmful additives.

If you choose to use CBD oil, always discuss it with your healthcare provider to ensure it doesn't interact with your prescription medications. CBD is not appropriate for pregnancy, breastfeeding, or in children.

Frequently Asked Questions

  • Is one type of CBD oil better than another?

    CBD oil comes in different forms:

    • Isolates contain only CBD.
    • Broad-spectrum oils have nearly all of the components of the plant (e.g., proteins, flavonoids, terpenes, and chlorophyll) but do not have THC.
    • Full-spectrum oils have all the compounds, including THC (up to 0.3%)

    While some healthcare practitioners believe that the compounds provide more health benefits, there's a lack of evidence to support these claims.

  • Are CBD oil and hemp oil the same?

    Not necessarily. While the names are sometimes used interchangeably, hemp oil can also refer to hemp seed oil, which is used for cooking, food production, and skincare products. CBD oil is made from the leaves, stems, buds, and flowers of the Cannabis indica or Cannabis sativa plant. It should contain less than 0.3% THC. Hemp oil is made from the seeds of Cannabis sativa and does not have TCH in it.

  • Is it possible to overdose on CBD oil?

    Yes. It's possible to overdose on CBD oil, especially in children. Dangerously slowed breathing has been noted in children who unintentionally ingested CBD oil. Many CBD products have been found to also contain THC, which poses risks like heightened anxiety when taken at high doses.

  • Can I buy CBD oil in all US states? Is traveling with it between states okay?

    The legality of buying and selling CBD is quite murky. In 2018, it became legal to sell CBD oil that comes from the hemp plant with less than 0.3% THC in it provided it is not marketed as a dietary supplement or claims to treat medical conditions.

    Most states now allow the sale of CBD with low levels of THC, though it is still illegal in some states.

    For state-specific guidelines before traveling, check out a site like State Medical Cannabis Laws from the National Conference of State Legislatures. Some states do not allow CBD that has been purchased in other states.

  • How can I make sure the product I buy is of high quality?

    Choose products with a certificate of analysis (COA) from an independent lab and/or from companies with current Good Manufacturing Practices (cGMP) certification. The COA means that the product has been tested for CBD and THC levels, along with possible contaminants. Because CBD comes from a plant, it is susceptible to chemicals like pesticides.

    Make sure the lab making the product also meets ISO 17025 standards, which shows high scientific standards are met. The FDA has issued several warning levels to companies whose products are mislabeled or adulterated (they contain potentially unsafe ingredients that can make you sick). Check them out here and avoid buying these products if possible.

  • Can taking CBD cause a positive drug test?

    Studies have shown that pure CBD will not cause a positive urine drug screen, as these are designed to measure THC. However, CBD products such as full-spectrum oils that contain THC may result in positive drug tests.

  • Is CBD oil safe for pets?

    Not enough is known about CBD use in animals. Always discuss with a veterinarian before using a CBD product for your pet. The FDA suggests keeping an eye out for the following side effects: sleepiness, depression, heavy drooling, vomiting, agitation, tremors, and convulsions.

  • Can CBD oil get you high?

    As mentioned, CBD oil is from a plant (hemp, typically Cannabis ruderalis). Hemp is in the same family as the marijuana plant. However, CBD oil does not typically produce the feelings of euphoria that can make someone feel "high."

    The reason why is that it does not contain enough tetrahydrocannabinol (THC). THC is the compound responsible for causing euphoria and other potential emotions, like paranoia.

52 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. Lowe H, Toyang N, Steele B, Bryant J, Ngwa W. The endocannabinoid system: a potential target for the treatment of various diseases. International Journal of Molecular Sciences. 2021;22(17):9472. doi:10.3390/ijms22179472

  2. Sholler DJ, Schoene L, Spindle TR. Therapeutic efficacy of cannabidiol (CBD): A review of the evidence from clinical trials and human laboratory studies. Curr Addict Rep. 2020;7(3):405-412. doi:10.1007/s40429-020-00326-8

  3. Thomas BF, Wiley JL, Gourdet CK, Wiley JL, Gourdet CK, Thomas BF. Cannabidiol: Science, marketing, and legal perspectives. RTI Press. Published online April 20, 2020.

  4. U.S. Food and Drug Administration. FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy. June 25, 2018.

  5. Peruca E. Cannabinoids in the treatment of epilepsy: Hard evidence at last? J Epilepsy Res. 2017 Dec;7(2):61-76. doi:10.14581/jer.17012

  6. Food and Drug Administration. FDA Approves New Indication for Drug Containing an Active Ingredient Derived from Cannabis to Treat Seizures in Rare Genetic Disease

  7. Aishworiya R, Valica T, Hagerman R, Restrepo B. An update on psychopharmacological treatment of autism spectrum disorder. Neurotherapeutics. doi:10.1007/s13311-022-01183-1

  8. Bilbao A, Spanagel R. Medical cannabinoids: A pharmacology-based systematic review and meta-analysis for all relevant medical indications. BMC Med. 2022;20(1):259. doi:10.1186/s12916-022-02459-1

  9. Babayeva M, Assefa H, Basu P, Chumki S, Loewy Z. Marijuana compounds: A nonconventional approach to Parkinson's disease therapy. Parkinsons Dis. 2016;2016:1279042. doi:10.1155/2016/1279042

  10. Blessing EM, Steenkamp MM, Manzanares J, Marmar CR. Cannabidiol as a potential treatment for anxiety disorders. Neurotherapeutics. 2015;12(4):825-36. doi:10.1007/s13311-015-0387-1

  11. Linares IM, Zuardi AW, Pereira LC, et al. Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test. Braz J Psychiatry. 2019 Jan-Feb;41(1):9-14. doi:10.1590/1516-4446-2017-0015

  12. Masataka N. Anxiolytic effects of repeated cannabidiol treatment in teenagers with social anxiety disorders. Frontiers in Psychology. 2019;10. doi:10.3389/fpsyg.2019.02466

  13. Karimi-Haghighi S, Razavi Y, Iezzi D, et al. Cannabidiol and substance use disorder: Dream or reality. Neuropharmacology. 2022;207:108948. doi:10.1016/j.neuropharm.2022.108948

  14. McGuire P, Robson P, Cubala WJ, et al. Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: A multicenter randomized controlled trial. Am J Psychiatry. 2018;175(3):225-231. doi:10.1176/appi.ajp.2017.17030325

  15. Arseneault L, Cannon M, Poulton R, et al. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective studyBMJ. 2002;325(7374):1212-1213. doi:10.1136/bmj.325.7374.1212

  16. Kolla BP, Hayes L, Cox C, Eatwell L, Deyo-Svendsen M, Mansukhani MP. The effects of cannabinoids on sleep. J Prim Care Community Health. 2022;13:21501319221081277. doi:10.1177/21501319221081277

  17. Babson KA, Sottile J, Morabito D. Cannabis, cannabinoids, and sleep: a review of the literature. Curr Psychiatry Rep. 2017;19(4):23. doi:10.1007/s11920-017-0775-9

  18. Spanagel R, Bilbao A. Approved cannabinoids for medical purposes - Comparative systematic review and meta-analysis for sleep and appetite. Neuropharmacology. 2021;196:108680. doi:10.1016/j.neuropharm.2021.108680

  19. Corroon J. Cannabinol and sleep: Separating fact from fiction. Cannabis Cannabinoid Res. 2021;6(5):366-371. doi:10.1089/can.2021.0006

  20. Kumric M, Bozic J, Dujic G, Vrdoljak J, Dujic Z. Chronic effects of effective oral cannabidiol delivery on 24-h ambulatory blood pressure and vascular outcomes in treated and untreated hypertension (HYPER-H21-4): Study protocol for a randomized, placebo-controlled, and crossover study. J Pers Med. 2022;12(7):1037. doi:10.3390/jpm12071037

  21. Scheau C, Badarau IA, Mihai LG, et al. Cannabinoids in the pathophysiology of skin inflammation. Molecules. 2020;25(3):652. doi:10.3390/molecules25030652

  22. Hammell DC, Zhang LP, Ma F, et al. Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis. European Journal of Pain. 2015;20(6):936-948. doi:10.1002/ejp.818

  23. Boyaji S, Merkow J, Elman RNM, et al. The role of cannabidiol (CBD) in chronic pain management: an assessment of current evidence. Current Pain and Headache Reports. 2020;24(2). doi:10.1007/s11916-020-0835-4

  24. Martínez V, Iriondo De-Hond A, Borrelli F, et al. Cannabidiol and other non-psychoactive cannabinoids for prevention and treatment of gastrointestinal disorders: useful nutraceuticals? International Journal of Molecular Sciences. 2020;21(9). doi:10.3390/ijms21093067

  25. Laux LC, Bebin EM, Checketts D, et al. Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results. Epilepsy research. 2019;154:13-20. doi:10.1016/j.eplepsyres.2019.03.015

  26. Iffland K, Grotenhermen F. An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies. Cannabis Cannabinoid Res. 2017;2(1):139-154. doi:10.1089/can.2016.0034

  27. Bonn-Miller MO, Loflin MJE, et al. Labeling accuracy of cannabidiol extracts sold online. JAMA. 2017;318(17):1708–1709. doi:10.1001/jama.2017.11909

  28. Legare CA, Raup-Konsavage WM, Vrana KE. Therapeutic potential of cannabis, cannabidiol, and cannabinoid-based pharmaceuticals. Pharmacology. 2022;107(3-4):131-149. doi:10.1159/000521683

  29. Cloak CC, Alicata D, Ernst TM, Chang L. Psychiatric symptoms, salivary cortisol and cytokine levels in young marijuana users. J Neuroimmune Pharmacol. 2015;10(2):380-390. doi:10.1007/s11481-015-9606-0

  30. Miller S, Daily L, Leishman E, Bradshaw H, Straiker A. Δ9-tetrahydrocannabinol and cannabidiol differentially regulate intraocular pressure. Invest Ophthalmol Vis Sci. 2018;59:5904-5911. doi:10.1167/iovs.18-24838

  31. Food and Drug Administration–Office of the Commissioner. What you should know about using CBD when pregnant or breastfeeding.

  32. Ryan SA, Ammerman SD, O'Connor ME. Marijuana use during pregnancy and breastfeeding: Implications for neonatal and childhood outcomes. Pediatrics. 2018;142(3) doi:10.1542/peds.2018-1889

  33. Food and Drug Administration–Office of the Commissioner. What to know about products containing cannabis and CBD

  34. Food and Drug Administration. FDA regulation of cannabis and cannabis-derived products, including cannabidiol (CBD).

  35. Centers for Disease Control. About CBD.

  36. Balachandran P, Elsohly M, Hill KP. Cannabidiol interactions with medications, illicit substances, and alcohol: A comprehensive review. Journal of General Internal Medicine. doi:10.1007/s11606-020-06504-8

  37. Good P, Haywood A, Gogna G, et al. Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: A double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD). BMC Palliat Care. 2019;18(1):110. doi:10.1186/s12904-019-0494-6

  38. Bebee B, Taylor DM, Bourke E, et al. The CANBACK trial: a randomised, controlled clinical trial of oral cannabidiol for people presenting to the emergency department with acute low back pain. Med J Aust. 2021;214(8):370-375. doi:10.5694/mja2.51014

  39. Boggs DL, Surti T, Gupta A, et al. The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial. Psychopharmacology. 2018;235(7):1923-1932. doi:10.1007/s00213-018-4885-9

  40. Chesney E, Oliver D, Green A, et al. Adverse effects of cannabidiol: A systematic review and meta-analysis of randomized clinical trials. Neuropsychopharmacology. 2020;45(11):1799-1806. doi:10.1038/s41386-020-0667-2

  41. Herbst J, Musgrave G. Respiratory depression following an accidental overdose of a CBD-labeled product: A pediatric case report. J Am Pharm Assoc (2003). 2020;60(1):248-252. doi:10.1016/j.japh.2019.09.023

  42. Yarrow G. How the 2023 farm bill could change the game for THC products. The Hill. Published online March 21, 2023.

  43. O’Mathúna D, Larimore WL. Dietary supplements - the wild west of good, bad, and a whole lotta ugly. The Medical Clinics of North America. 2022;106(5):881-898. doi:10.1016/j.mcna.2022.03.004

  44. Cather JC, Cather JC. Cannabidiol primer for healthcare professionalsProc (Bayl Univ Med Cent). 2020;33(3):376-379. doi:10.1080/08998280.2020.1775437

  45. VanDolah HJ, Bauer BA, Mauck KF. Clinicians' guide to cannabidiol and hemp oils. Mayo Clin Proc. 2019;94(9):1840-1851. doi:10.1016/j.mayocp.2019.01.003

  46. Bergamaschi MM, Queiroz RH, Zuardi AW, Crippa JA. Safety and side effects of cannabidiol, a cannabis sativa constituentCurr Drug Saf. 2011;6(4):237-249. doi:10.2174/157488611798280924

  47. Sharpe L, Sinclair J, Kramer A, de Manincor M, Sarris J. Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties. J Transl Med. 2020;18(1):374. Published 2020 Oct 2. doi:10.1186/s12967-020-02518-2

  48. Food and Drug Administration. Guidance for industry, Q7A good manufacturing practice guidance for active pharmaceutical ingredients.

  49. Macchi Silva VV, Ribeiro JLD. Obtaining laboratory accreditation – required activities. International Journal of Health Care Quality Assurance. 2019;32(1):71-83. doi:10.1108/ijhcqa-10-2017-0191

  50. Spindle TR, Cone EJ, Kuntz D, et al. Urinary pharmacokinetic profile of cannabinoids following administration of vaporized and oral cannabidiol and vaporized CBD-dominant cannabis. Journal of Analytical Toxicology. 2019;44(2):109-125. doi:10.1093/jat/bkz080

  51. Office of the Commissioner. FDA regulation of cannabis and cannabis-derived products, including cannabidiol (CBD). FDA. Published online January 22, 2021

  52. Franco V, Perucca E. Pharmacological and therapeutic properties of cannabidiol for epilepsy. Drugs. 2019;79(13):1435-1454. doi:10.1007/s40265-019-01171-4

Megan Nunn headshot

By Megan Nunn, PharmD
Nunn is a community pharmacist in Tennessee with 12 years of experience in medication counseling and immunization.